What Causes Cell Death in Parkinson's Disease?

被引：99

作者：

Gupta, Amitabh ^{[1
]}

Dawson, Valina L. ^{[1
,2
,3
,4
]}

Dawson, Ted M. ^{[1
,2
,4
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA

[4] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA

来源：

ANNALS OF NEUROLOGY | 2008年 / 64卷 / 06期

关键词：

D O I：

10.1002/ana.21573

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Currently, there is no proven neuroprotective or neurorestorative therapy for Parkinson's disease (PD). Several advances in the genetics of PD have created an opportunity to develop mechanistic-based therapies that hold particular promise for identifying agents that slow and even halt the progression of PD, as well as restore function. Here we review many of the advances in the last decade regarding the identification of new targets for the treatment of PD based on understanding the molecular mechanisms of how mutations in genes linked to PD cause neurodegeneration.

引用

页码：S3 / S15

页数：13

共 121 条

[31] Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions [J].

Engelender, S ;

Kaminsky, Z ;

Guo, X ;

Sharp, AH ;

Amaravi, RK ;

Kleiderlein, JJ ;

Margolis, RL ;

Troncoso, JC ;

Lanahan, AA ;

Worley, PF ;

Dawson, VL ;

Dawson, TM ;

Ross, CA .

NATURE GENETICS, 1999, 22 (01) :110-114

[32] Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin [J].

Exner, Nicole ;

Treske, Bettina ;

Paquet, Dominik ;

Holmström, Kira ;

Schiesling, Carola ;

Gispert, Suzana ;

Carballo-Carbajal, Iria ;

Berg, Daniela ;

Hoepken, Hans-Hermann ;

Gasser, Thomas ;

Kr ger, Rejko ;

Winklhofer, Konstanze F. ;

Vogel, Frank ;

Reichert, Andreas S. ;

Auburger, Georg ;

Kahle, Philipp J. ;

Schmid, Bettina ;

Haass, Christian .

JOURNAL OF NEUROSCIENCE, 2007, 27 (45) :12413-12418

[33] A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling [J].

Fallon, Lara ;

Belanger, Catherine M. L. ;

Corera, Amadou T. ;

Kontogiannea, Maria ;

Regan-Klapisz, Elsa ;

Moreau, France ;

Voortman, Jarno ;

Haber, Michael ;

Rouleau, Genevieve ;

Thorarinsdottir, Thorhildur ;

Brice, Alexis ;

Henegouwen, Paul M. P. van Bergen en ;

Fon, Edward A. .

NATURE CELL BIOLOGY, 2006, 8 (08) :834-U87

[34] Lrrk2 in the limelight! [J].

Farrer, Matthew J. .

NEUROLOGY, 2007, 69 (18) :1732-1733

[35] RNA interference-mediated knockdown of α-synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport [J].

Fountaine, Timothy M. ;

Wade-Martins, Richard .

JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (02) :351-363

[36] Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain [J].

Fuchs, Julia ;

Tichopad, Ales ;

Golub, Yulia ;

Munz, Marita ;

Schweitzer, Katherine J. ;

Wolf, Bjoern ;

Berg, Daniela ;

Mueller, Jakob C. ;

Gasser, Thomas .

FASEB JOURNAL, 2008, 22 (05) :1327-1334

[37] Plasma membrane ion permeability induced by mutant α-synuclein contributes to the degeneration of neural cells [J].

Furukawa, K ;

Matsuzaki-Kobayashi, M ;

Hasegawa, T ;

Kikuchi, A ;

Sugeno, N ;

Itoyama, Y ;

Wang, Y ;

Yao, PJ ;

Bushlin, I ;

Takeda, A .

JOURNAL OF NEUROCHEMISTRY, 2006, 97 (04) :1071-1077

[38] Linking SIRT2 to Parkinson's disease [J].

Garske, Adam L. ;

Smith, Brian C. ;

Denu, John M. .

ACS CHEMICAL BIOLOGY, 2007, 2 (08) :529-532

[39] Update on the genetics of Parkinson's disease [J].

Gasser, Thomas .

MOVEMENT DISORDERS, 2007, 22 :S343-S350

[40] Are ubiquitination pathways central to Parkinson's disease? [J].

Giasson, BI ;

Lee, VMY .

CELL, 2003, 114 (01) :1-8

← 1 2 3 4 5 6 7 8 9 10 →